Radioimmunoassay (RIA)

108

Radioimmunoassay (RIA) was introduced into medical practice still before the enzyme immunoassay. At first, it had many practical applications. By means of RIA, it became possible to test a large number of samples in a very short period of time using very small amounts of reagents.

  • Nevertheless, being more difficult in handling, RIA required high-cost equipment, radioactive isotopes and special safety measures.
  • Thus, it is being ousted by EIA. Now RIA is used predominantly to determine the quantity of antigens or haptens that can be radioactively labelled.
  • These antigens are usually the substances of low molecular weight (drugs, chemicals, toxins, etc.)
  • This variation of RIA is based on the competition for specific antibody between the labelled and non-labelled antigen of unknown concentration (competitive RIA).
  • In this case, the specific antibodies are adsorbed on the solid phase (e.g. plastic globular particles). The known quantity of labelled antigen is added to Ab-coated particles.
  • Usually, 125I or 131I isotopes are used here as a radioactive tag. After antigenantibody binding, the immune complexes are formed.
  • Then the clinical samples containing the unknown concentrations of an Ag are introduced into the system.
  • The unlabeled antigens start to replace the labelled antigens in Ab-Ag-complex. This replacement is proportional to the unknown antigenic concentration in the sample.
  • As a result, the labelled antigens are released from the solid phase to the surrounding liquid medium.
  • After the separation of solid and liquid phases of the reaction, the amount of radioactivity is measured using a counter for radioactivity.
  • The concentration of the unknown (non-labelled) antigen or hapten is determined by comparing the results with those obtained with several concentrations of a pre-determined standard antigen.
  • This method can detect less than 1 ng/ml of an antigen.
  • RIA is an extremely sensitive method applied to the assay of hormones or drugs in biological fluids. A specialized RIA, the radioallergosorbent test (RAST), is used to estimate the quantity of serum IgE antibodies that react with a known allergen (antigen).

Radioimmunoassay (RIA)